Infectious diseases news and infectious diseases widget

Commits $34 Million for New Institute to Eradicate the Ill Effects of the Condition (PRWeb Oct 24, 2008) Read the full story at http://www.prweb.com/releases/Down_Syndrome/Medical_Research/prweb1519874.htm

Background: Nitric oxide (NO) is essential for host defense in rodents, but the role of NO during tuberculosis (TB) in man remains controversial. However, earlier observations that arginine supplementation facilitates anti-TB treatment, supports the hypothesis that NO is important in the host defense against TB. Local production of NO measured in fractional exhaled air (FeNO) in TB patients with and without HIV co-infection has not been reported previously. Thus, our aim was to investigate levels of FeNO in relation to clinical symptoms and urinary NO metabolites (uNO). Methods: In a cross sectional study, FeNO and uNO were measured and clinical symptoms, chest x-ray, together with serum levels of arginine, tumor necrosis factor alpha (TNF-alpha) and interleukin 12 (IL-12) were evaluated in sputum smear positive TB patients (HIV+/TB, n=36, HIV-/TB, n=59), their household contacts (n=17) and blood donors (n=46) from Gondar University hospital, Ethiopia. Results: The proportion of HIV-

Retirement Living TV Premieres Polio Revisited Documentary on October 24, 2008 - "World Polio Day"50+ Network Rallies Constituents to Relay Importance of Polio Vaccination to Their Children (PRWeb Oct 24, 2008) Read the full story at http://www.prweb.com/releases/2008/10/prweb1511204.htm

The number one reason why children miss School is because of head lice. With having so many things to worry about such as tests, homework and events head lice no longer needs to be such a worry for children or parents. Lice Busters Inc. is the first of its kind in South Carolina. Lice Busters Inc. goes into the homes of its clients and removes head lice from the client with all natural products. (PRWeb Oct 24, 2008) Read the full story at http://www.prweb.com/releases/2008/10/prweb1334584.htm

(Procter & Gamble) Results from the first comprehensive study of the human body's response to the common cold virus confirm that an over-response of the immune system, and not the rhinovirus itself, results in symptoms. This data provides a genomic roadmap in the search for new treatments by identifying several therapeutic targets that could balance the immune response in order to minimize symptoms during an infection and potentially lead to therapies that prevent infection.

(Edelman Public Relations) MedImmune announced today it will present nine abstracts at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/46th Annual Meeting of Infectious Disease Society of America. These abstracts advance the knowledge about respiratory syncytial virus and influenza, providing valuable insight into infectious disease prevention and underscoring MedImmune's leadership in this disease category.